About
Jeremy Koff is a medtech and neurotechnology executive, consultant, and industry media figure focused on neuromodulation and neuroprosthetic devices. Neurotech Reports named him a senior contributing editor in 2017, and he has since moderated industry sessions and contributed reporting across the neurotech ecosystem. Public materials also describe him as leading Trillen Medical and advising early-stage companies through Colibri Partners, with earlier work tied to firms including Advanced Bionics, Boston Scientific, Bioness, Eyenuk, and Leonhardt Ventures.
Areas of interest
neurotechnologyneuromodulationmedical devicesbioelectronic medicinemedtech commercializationstartup strategyclinical developmentregulatory strategymusic